Development of a fully human anti‐GITR antibody with potent antitumor activity using H2L2 mice

Development of a fully human anti‐GITR antibody with potent antitumor activity using H2L2 mice

Glucocorticoid‐induced TNF receptor‐related (GITR) can act as a co‐stimulatory receptor, representing a potential target for safely enhancing immunotherapy efficacy. GITR is triggered by a GITR ligand or an agonist antibody and activates CD8+ and CD4+ effector T cells, reducing tumor‐infiltrating Tr...

Full description

Bibliographic Details
Main Authors:	Qiuli Tong, Hu Liu, Qianqian Qi, Chaohui Dai, Teddy Yang, Feng Qian
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	FEBS Open Bio
Subjects:	engineering modification fully human antibody GITR H2L2 mice immunization strategies T cell
Online Access:	https://doi.org/10.1002/2211-5463.13451

Similar Items

MEDI1873, a potent, stabilized hexameric agonist of human GITR with regulatory T-cell targeting potential
by: Natalie J. Tigue, et al.
Published: (2017-03-01)

Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy
by: Rajeev Shrimali, et al.
Published: (2017-08-01)

Combination with Toll-like receptor 4 (TLR4) agonist reverses GITR agonism mediated M2 polarization of macrophage in Hepatocellular carcinoma
by: Caixu Pan, et al.
Published: (2022-12-01)

The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses
by: Isabel eBarao
Published: (2013-01-01)

GITR Promotes the Polarization of TFH-Like Cells in Helicobacter pylori-Positive Gastritis
by: Siqi Ming, et al.
Published: (2021-09-01)

Peritumoral administration of DRibbles-pulsed antigen-presenting cells enhances the antitumor efficacy of anti-GITR and anti-PD-1 antibodies via an antigen presenting independent mechanism
by: Jaina M. Patel, et al.
Published: (2019-11-01)

Atypical TNF-TNFR superfamily binding interface in the GITR-GITRL complex for T cell activation
by: Min Zhao, et al.
Published: (2021-09-01)

Anti-glucocorticoid-induced Tumor Necrosis Factor–Related Protein (GITR) Therapy Overcomes Radiation-Induced Treg Immunosuppression and Drives Abscopal Effects
by: Jonathan E. Schoenhals, et al.
Published: (2018-09-01)

The intracellular portion of GITR enhances NGF-promoted neurite growth through an inverse modulation of Erk and NF-κB signalling
by: Laura McKelvey, et al.
Published: (2012-08-01)

GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
by: Nick M. Durham, et al.
Published: (2017-06-01)

Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity
by: R. Gerli, et al.
Published: (2012-12-01)

GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers
by: Anuja Sathe, et al.
Published: (2023-11-01)

Glucocorticoid-induced TNF receptor family related protein ligand [GITR-L] is requisite for optimal functioning of regulatory CD4+ T cells.
by: Gongxian eLiao, et al.
Published: (2014-02-01)

CD4+ T Cell Fate Decisions Are Stochastic, Precede Cell Division, Depend on GITR Co-Stimulation, and Are Associated With Uropodium Development
by: Stephen P. Cobbold, et al.
Published: (2018-06-01)

Discovery and characterization of SARS-CoV-2 reactive and neutralizing antibodies from humanized CAMouseHG mice through rapid hybridoma screening and high-throughput single-cell V(D)J sequencing
by: Xi Yang, et al.
Published: (2022-09-01)

In vivo fluctuation of Tax, Foxp3, CTLA-4, and GITR mRNA expression in CD4+CD25+ T cells of patients with human T-lymphotropic virus type 1-associated myelopathy
by: E. Ramirez, et al.
Published: (2010-11-01)

2-Visible Submodules and Fully 2-Visible Modules
by: Mahmood S. Fiadh, et al.
Published: (2020-07-01)

On Fully Semiprime Submodules and Fully Semiprime Modules
by: I.M.A. Hadi, et al.
Published: (2017-05-01)

A Fully Human Monoclonal Antibody Targeting cKIT Is a Potent Inhibitor of Pathological Choroidal Neovascularization in Mice
by: Songyi Seo, et al.
Published: (2021-08-01)

Soluble glucocorticoid-induced tumor necrosis factor receptor regulates Helios expression in myasthenia gravis
by: Yi Li, et al.
Published: (2019-05-01)

A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice
by: Jinhao Bi, et al.
Published: (2023-12-01)

Fully Human Antibodies for Malignant Pleural Mesothelioma Targeting
by: Fabio Nicolini, et al.
Published: (2020-04-01)

Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes
by: Hodaka Nagai, et al.
Published: (2023-06-01)

Impaired intratumoral natural killer cell function in head and neck carcinoma
by: Dalila Mele, et al.
Published: (2022-10-01)

Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies
by: Daria Beshnova, et al.
Published: (2022-01-01)

HER2-Targeted Antibody–Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget’s Disease Models: In Vivo and Immunohistochemical Analyses
by: Keiko Tokuchi, et al.
Published: (2022-07-01)

Antibodies-Abzymes with Antioxidant Activities in Two Th and 2D2 Experimental Autoimmune Encephalomyelitis Mice during the Development of EAE Pathology
by: Anna S. Tolmacheva, et al.
Published: (2022-11-01)

Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
by: Sandro Halwe, et al.
Published: (2021-07-01)

Development of a stable eukaryotic strain producing fully human monoclonal antibody on the basis of the human antibody against ectromelia virus
by: A. L. Matveev, et al.
Published: (2018-01-01)

Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B
by: Takuhiro Matsumura, et al.
Published: (2020-05-01)

Bactericidal fully human single‐chain fragment variable antibodies protect mice against methicillin‐resistant Staphylococcus aureus bacteraemia
by: Behnoush Soltanmohammadi, et al.
Published: (2021-01-01)

A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo
by: Mehdi Mohammadi, et al.
Published: (2021-02-01)

A novel rabbit derived anti-HER2 antibody with pronounced therapeutic effectiveness on HER2-positive breast cancer cells in vitro and in humanized tumor mice (HTM)
by: Anja Kathrin Wege, et al.
Published: (2020-08-01)

Hyperoxidized Species of Heme Have a Potent Capacity to Induce Autoreactivity of Human IgG Antibodies
by: Marie Wiatr, et al.
Published: (2023-02-01)

Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4
by: Alaa Alsalloum, et al.
Published: (2023-10-01)

Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
by: Kübra Kaban, et al.
Published: (2021-11-01)

A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
by: Samantha M. Perez, et al.
Published: (2021-08-01)

Fully Human Herpesvirus-Specific Neutralizing IgG Antibodies Generated by EBV Immortalization of Splenocytes-Derived from Immunized Humanized Mice
by: Sebastian J. Theobald, et al.
Published: (2023-12-01)

Potential effect of tumor-specific Treg-targeted antibodies in the treatment of human cancers: A bioinformatics analysis
by: Luigi Cari, et al.
Published: (2018-02-01)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021-01-01)